SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical University of South Carolina
About this trial
This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care intervention for patients with Progressive Pulmonary Fibrosis (PPF) and their caregivers. The intervention includes a 9-week digital application guided by a nurse interventionist and quarterly virtual support groups over one year. Participants will be recruited from rural South Carolina and urban New York City. The study compares SUPPORT-T to Enhanced Usual Care and aims to inform a future multi-site trial.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults ≥18 years
Confirmed diagnosis of PPF
English or Spanish speaking
adult, ≥ 18 years old
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
SUPPORT-T Educational Intervention
Other interventionSUPPORT-T will be delivered biweekly at TeleHealth Visits 1-4 via a secure interface via MUSC telehealth platform. The nurse interventionist will receive results from the REDCap survey after each TH visit and contact the patient biweekly after each TH visit using the MUSC Telehealth and/or Health platform. The nurse interventionist will be available for any questions and communicate with the participants via bi-directional texts (SC will maintain a log of those texts)
Treatment groups
170 Participants
are divided into 2 treatment groupsGroup A: SUPPORT-T Intervention ArmExperimental treatment 1 intervention
Group B: Enhanced Usual Care Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Feasibility of Disease Preparedness
Feasibility outcomes include number of participants recruited weekly, number of participants who declined, and number of participants who did not meet eligibility requirements, data collection procedures, and participant responses. Feasibility data will inform future studies on approaches for recruitment and retention, study procedures, and timing and participant capacity to complete surveys/interviews.
Time frame
10 months2
Disease Preparedness Feasibility
Feasibility outcomes include number of participants recruited weekly, number of participants who declined, and number of participants who did not meet eligibility requirements, data collection procedures, and participant responses. Feasibility data will inform future studies on approaches for recruitment and retention, study procedures, and timing and participant capacity to complete surveys/interviews.
Time frame
10 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Medical University of South Carolina
Lead sponsor
National Institutes of Health (NIH)
Collaborator
Source ClinicalTrials.gov